POLESTAR Trial - An International Multi-center Early Discharge TAVI Program
Last updated on July 2021Recruitment
- Recruitment Status
- Enrolling by invitation
- Estimated Enrollment
- 250
Summary
- Conditions
- Aortic Valve Stenosis
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
In this International multi-center prospective observational study, 250 patients with severe symptomatic aortic stenosis (AS) and eligibility for transfemoral TAVI with ACURATE Neo Bioprosthesis, will be pre-procedurally selected for participation in an early discharge protocol in which patients are...
In this International multi-center prospective observational study, 250 patients with severe symptomatic aortic stenosis (AS) and eligibility for transfemoral TAVI with ACURATE Neo Bioprosthesis, will be pre-procedurally selected for participation in an early discharge protocol in which patients are discharged within 48 hours after uncomplicated TAVI.
Tracking Information
- NCT #
- NCT03910751
- Collaborators
- Boston Scientific Corporation
- Investigators
- Principal Investigator: Nicolas Van Mieghem, MD, PhD Erasmus Medical Center
Get Well Soon